Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Articles published by ProMIS Neurosciences Inc. ProMIS Neurosciences Announces Second Quarter 2024 Financial Results and Recent Highlights August 08, 2024 From ProMIS Neurosciences Inc. Via GlobeNewswire Tickers PMN ProMIS Neurosciences Announces Data on the Pathogenic Role of Toxic Misfolded SOD1 Aggregates in ALS Published in Acta Neuropathologica and Open Biology August 06, 2024 From ProMIS Neurosciences Inc. Via GlobeNewswire Tickers PMN ProMIS Neurosciences to Participate in BTIG Virtual Biotechnology Conference 2024 August 01, 2024 From ProMIS Neurosciences Inc. Via GlobeNewswire Tickers PMN ProMIS Neurosciences Showcases Novel Vaccine Approach for Maximal Targeting of Toxic Amyloid-Beta Oligomers at the 2024 Alzheimer’s Association International Conference July 30, 2024 From ProMIS Neurosciences Inc. Via GlobeNewswire Tickers PMN ProMIS Neurosciences Reports Positive Top-Line Data from its Phase 1a Alzheimer's Trial July 26, 2024 From ProMIS Neurosciences Inc. Via GlobeNewswire Tickers PMN ProMIS Neurosciences Announces Up to $122.7 Million Private Placement Financing July 26, 2024 From ProMIS Neurosciences Inc. Via GlobeNewswire Tickers PMN ProMIS Neurosciences Announces First Quarter 2024 Financial Results and Recent Highlights May 14, 2024 From ProMIS Neurosciences Inc. Via GlobeNewswire Tickers PMN TSX:PMN ProMIS Neurosciences Publishes Study Highlighting Oligomer Selectivity and Benefit of Amyloid-Beta-Directed Antibodies April 30, 2024 From ProMIS Neurosciences Inc. Via GlobeNewswire Tickers PMN TSX:PMN ProMIS Neurosciences Publishes in the Journal of Biological Chemistry on the Interaction Between Pathogenic Proteins as a Treatment Target for ALS April 09, 2024 From ProMIS Neurosciences Inc. Via GlobeNewswire Tickers PMN TSX:PMN ProMIS Neurosciences to Present in Upcoming Investor Conferences in April April 04, 2024 From ProMIS Neurosciences Inc. Via GlobeNewswire Tickers PMN TSX:PMN ProMIS Neurosciences Announces Full Year 2023 Financial Results and Recent Highlights April 01, 2024 From ProMIS Neurosciences Inc. Via GlobeNewswire Tickers PMN TSX:PMN ProMIS Neurosciences Strengthens Global Intellectual Property Portfolio March 11, 2024 From ProMIS Neurosciences Inc. Via GlobeNewswire Tickers PMN TSX:PMN ProMIS Neurosciences to Present at the 2024 BIO CEO & Investor Conference February 22, 2024 From ProMIS Neurosciences Inc. Via GlobeNewswire Tickers PMN TSX:PMN ProMIS Neurosciences Achieves Milestone in Development of Therapeutic Alpha-Synuclein Vaccine January 22, 2024 From ProMIS Neurosciences Inc. Via GlobeNewswire Tickers PMN TSX:PMN ProMIS Neurosciences Issues Letter to Shareholders January 08, 2024 From ProMIS Neurosciences Inc. Via GlobeNewswire Tickers PMN TSX:PMN ProMIS Neurosciences, Inc. Announces Leadership Transition January 03, 2024 From ProMIS Neurosciences Inc. Via GlobeNewswire Tickers PMN TSX:PMN ProMIS Neurosciences Announces Publication on Novel Target for ALS December 20, 2023 From ProMIS Neurosciences Inc. Via GlobeNewswire Tickers PMN TSX:PMN ProMIS Neurosciences Doses First Subjects in Phase 1a Clinical Trial of PMN310 to Treat Alzheimer’s Disease November 20, 2023 From ProMIS Neurosciences Inc. Via GlobeNewswire Tickers PMN TSX:PMN ProMIS Neurosciences Announces Third Quarter 2023 Financial Results and Recent Highlights November 14, 2023 From ProMIS Neurosciences Inc. Via GlobeNewswire Tickers PMN TSX:PMN ProMIS Neurosciences Closes $20.4 Million Private Placement Financing September 08, 2023 From ProMIS Neurosciences Inc. Via GlobeNewswire Tickers PMN TSX:PMN ProMIS Neurosciences to Present at the H.C. Wainwright 25th Annual Global Investment Conference September 06, 2023 From ProMIS Neurosciences Inc. Via GlobeNewswire Tickers PMN TSX:PMN ProMIS Neurosciences Announces $20.4 Million Private Placement Financing August 21, 2023 From ProMIS Neurosciences Inc. Via GlobeNewswire Tickers PMN TSX:PMN ProMIS Neurosciences Announces Second Quarter 2023 Financial Results and Recent Highlights August 14, 2023 From ProMIS Neurosciences Inc. Via GlobeNewswire Tickers PMN TSX:PMN ProMIS Showcases Preclinical Data at the Alzheimer’s Association International Conference 2023 on Computationally-Derived Antibody and Vaccine from Alzheimer’s Pipeline July 17, 2023 From ProMIS Neurosciences Inc. Via GlobeNewswire Tickers PMN TSX:PMN ProMIS Announces Completion of Continuance July 14, 2023 From ProMIS Neurosciences Inc. Via GlobeNewswire Tickers PMN TSX:PMN ProMIS Neurosciences to Consolidate Trading on the Nasdaq Exchange July 10, 2023 From ProMIS Neurosciences Inc. Via GlobeNewswire Tickers PMN TSX:PMN ProMIS Neurosciences Holds Annual Meeting of Shareholders All Resolutions Approved June 30, 2023 From ProMIS Neurosciences Inc. Via GlobeNewswire Tickers PMN TSX:PMN CORRECTION: Updated URL to Access ProMIS Annual Meeting of Shareholders on June 29, 2023 at 9:30am Eastern Time June 29, 2023 From ProMIS Neurosciences Inc. Via GlobeNewswire Tickers PMN TSX:PMN ProMIS Neurosciences Announces First Quarter 2023 Financial Results and Recent Highlights May 15, 2023 From ProMIS Neurosciences Inc. Via GlobeNewswire Tickers PMN TSX:PMN ProMIS Neurosciences Announces FDA Clearance of Investigational New Drug (IND) Application for PMN310 in Alzheimer’s Disease May 08, 2023 From ProMIS Neurosciences Inc. Via GlobeNewswire Tickers PMN TSX:PMN Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.